Zacks Investment Research on MSN
SENS stock up as Eversense 365 CGM wins European CE mark approval
Senseonics Holdings, Inc. SENS recently scored a meaningful regulatory win in Europe, receiving CE Mark approval for its ...
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
Stocktwits on MSN
Why did Glucotrack stock surge 12% pre-market today?
Following the update, Glucotrack stock traded over 12% higher in Thursday’s premarket. New Patents Strengthen IP The US ...
The first fully implantable continuous glucose monitors can now be integrated with insulin pumps as part of an automated insulin delivery system As the first fully implantable device in the category, ...
Credit: Ascensia Diabetes Care. Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management. The FDA has designated the Eversense 365 ...
WAN CHAI, WAN CHAI, HONG KONG, January 23, 2026 /EINPresswire.com/ -- Even with the advancement of Automated Insulin ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM), today announced that the Tandem Mobi insulin pump with Control-IQ technology is now fully ...
“When AID systems are used in conjunction with real-time CGM, people with diabetes experience more time in range, fewer incidences of hypoglycemia and greater peace of mind,” said Dr. Nicholas Argento ...
Dr Anne Peters discusses updates in the ADA 2026 Standards of Care in Diabetes, focusing on the use of technology.
Please provide your email address to receive an email when new articles are posted on . The Tandem Mobi automated insulin delivery system can be integrated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results